REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA® ATRIAL SHUNT ...Middle East

Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy TEWKSBURY, Mass., April 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its...

Read More Details
Finally We wish PressBee provided you with enough information of ( REDUCE LAP-HF II ANALYSES SHOW 50% OF STUDY PATIENTS DEMONSTRATED SIGNIFICANT CLINICAL BENEFIT FROM THE CORVIA® ATRIAL SHUNT )

Also on site :

• Terrorist plot foiled in Russia’s Kaliningrad – FSB
• Old Navy Is Selling a 'Very Comfortable' Mini Dress for Just $17, and Shoppers Say It’s 'Perfect' for Summer
• Your Next 3 Years: What Happens When Saturn Enters Aries